12.07.2015 Views

Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

468$15, $17, <strong>and</strong> $19 million, just to give you a sense of some modestincrease in the <strong>research</strong> efforts.Mr. Perito. If I underst<strong>and</strong> it correctly, in fiscal 1971, $7,987,000was spent directly by NIMH on drug abuse <strong>research</strong>; is that correct?Dr. Brown. Yes.:\Ir. Perito. And in 1972, $9,325,000 will be spent?Dr. Brown. I do not know which subfigures j^ou are adding. Oneof the issues, Mr. Perito, is that we spend approximately—the figuresyou said—$6 or $7 million in drug abuse, that is on the amphetamines<strong>and</strong> barbiturates, heroin, cocaine, et cetera. We do have a very importantpsychopharmacolog}^ <strong>research</strong> program that looks at alldrug use <strong>and</strong> enhances our <strong>research</strong> endeavors, that $9.8 million, soAvhen we give you the figure of $17 or $19 million <strong>and</strong> that is why webroke itdoM'n, one must distinguish between the subportion, roughh'a third, that is, on drug abuse, clearly drugs of abuse, as opposed topsA'chopharmacolog}^ or drug use. So, the relationships from the<strong>research</strong> point of view, I am sure are clear to you.Mr. Perito. Two final questions. What was the dem<strong>and</strong> for fundsthis past year for <strong>research</strong> in the area of narcotic antagonist?Dr. Brown. I do not know the answer for that. Dr. Martin, is thatsomething you are aware of?Dr. Martin. No.Dr. Brown. There was slightly more dem<strong>and</strong> than we had resourcesfor. That I can say, but not a heck of a lot.Mr. Perito. So, you turned down some requests for <strong>research</strong> in thearea of antagonists?Dr. Brown. Not for antagonists per se. In relation to the antagonistswe funded all the <strong>research</strong> that has come to us or that we could find.Mr. Perito. One final question for Dr. Martin. Dr. Martin, I takeit from your testimony, that the resources available to private hidustry,insofar as laboratory facilities capable of jjerforming toxicity studiesare concerned, far exceed anj'thing our Government has available to it.Is that a fair statement?Dr. Martin. Yes; I think so.Mr. Perito. In your professional judgment, would it be worthwhilefor our Government to greatly exj^<strong>and</strong> its laboratory facilities to dotoxicity testing insofar as narcotics <strong>research</strong> is concerned?Dr. Martin. Yes; I think this woidd be most helpful <strong>and</strong> mostnecessary.Mr. Perito. Thank you. Mr. Chairman.Chairman Pepper. Mr. Blommer?Mr. Blommer. I have just one comment, Mr. Chau'man, to enlightenour record <strong>and</strong> maybe Dr. Brown. Dr. Revici has no facilities forfollowing up on the 1,700 people he has given Perse except for tht^ 2Aveeks he is in direct contact ^\ ith them. So, I tliink that CongressmanSteiger was a little bit misstating a point to saj^ that they are fine. ButI would add a note of hope <strong>and</strong> that is that the assistant coroner ofNew York (^ity has never heard Dr. Revici's name.That is all I have.Chairman Pepper. The last comment— that suggests the ])ossibilitythat if you had somebody like Dr. Revici, who might not be verygood at recordkeeping, not very good in kee])ing his files <strong>and</strong> thewritten data, would it be within the scope of your authority to help

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!